Frontiers Case report: Short-term eculizumab use in atypical HUS
Por um escritor misterioso
Descrição
COVID-19 Triggers Relapse in Woman With aHUS: Case Study
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
Eculizumab for Atypical Hemolytic–Uremic Syndrome
Frontiers Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation
PDF] Atypical hemolytic uremic syndrome: a syndrome in need of clarity
PDF] Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab
Optimal management of atypical hemolytic uremic disease: challenges an
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
PDF] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
de
por adulto (o preço varia de acordo com o tamanho do grupo)
